Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral nerve stimulation & intrathecal pumps · Washington | Peripheral nerve stimulation & intrathecal pumps · California | |
|---|---|---|
| Surgeons, 2024 | 8 | 35 |
| Medicare fee-for-service cases | 573 | 2,932 |
| Growth since 2019 (Medicare FFS) | +7.4%/yr | +9.5%/yr |
| Forecast cases (Medicare FFS) | 1,090 in 2030 | 6,310 in 2030 |
| Forecast growth | +11%/yr to 2030 | +14%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.7 | 0.8 |
| Medicare Advantage share | 54% | 56% |
| Out of hospital | 55% (+48 pts since 2019) | 78% (+20 pts since 2019) |
| Cases per surgeon | 72 | 84 |
| Top 10 surgeons' share | 100% | 55% |
| Surgeons growing | 1 | 4 |
| New since the base year | 1 | 16 |
| Likely to stop billing it | 5 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 11% | 11% |
| Company payments per surgeon | $7,634 | $18K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.